Xenetic Biosciences Stock Alpha and Beta Analysis
| XBIO Stock | USD 4.04 0.07 1.70% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Xenetic Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Xenetic Biosciences over a specified time horizon. Remember, high Xenetic Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Xenetic Biosciences' market risk premium analysis include:
Beta 0.35 | Alpha (0.01) | Risk 4.97 | Sharpe Ratio 0.048 | Expected Return 0.24 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Xenetic |
Xenetic Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Xenetic Biosciences market risk premium is the additional return an investor will receive from holding Xenetic Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Xenetic Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Xenetic Biosciences' performance over market.| α | -0.0087 | β | 0.35 |
Xenetic Biosciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Xenetic Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Xenetic Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Xenetic Biosciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Xenetic Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Xenetic Biosciences shares will generate the highest return on investment. By understating and applying Xenetic Biosciences stock market price indicators, traders can identify Xenetic Biosciences position entry and exit signals to maximize returns.
Xenetic Biosciences Return and Market Media
The median price of Xenetic Biosciences for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 3.87 with a coefficient of variation of 6.06. The daily time series for the period is distributed with a sample standard deviation of 0.24, arithmetic mean of 3.92, and mean deviation of 0.19. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Xenetic Biosciences Inc Sees Significant Decline in Short Interest - Defense World | 09/12/2024 |
2 | Xenetic Biosciences, Inc. Enters into Materials Transfer Agreement with Tokyo Medical University for the Advancement of Its DNase-Based Oncology Platform | 10/17/2024 |
3 | Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer 2024 | 10/22/2024 |
4 | Acquisition by Kornberg Roger D. of 25000 shares of Xenetic Biosciences at 1.44 subject to Rule 16b-3 | 10/29/2024 |
5 | Acquisition by James Parslow of 20000 shares of Xenetic Biosciences at 3.99 subject to Rule 16b-3 | 11/04/2024 |
6 | Xenetic Biosciences, Inc. Presents Positive Data Demonstrating DNase I Significantly Improves Efficacy of Anti-CTLA-4 Immune Checkpoint Blockade in Preclinical ... | 11/12/2024 |
7 | Xenetic Biosciences Third Quarter 2024 Earnings Misses Expectations - Yahoo Finance | 11/15/2024 |
8 | Xenetic Biosciences, Inc. Releases Virtual Investor What This Means Segment | 11/22/2024 |
About Xenetic Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Xenetic or other stocks. Alpha measures the amount that position in Xenetic Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Days Sales Outstanding | 328.5 | 192.59 | PTB Ratio | 0.54 | 0.5 |
Xenetic Biosciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Xenetic Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Xenetic Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Xenetic Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Xenetic Biosciences. Please utilize our Beneish M Score to check the likelihood of Xenetic Biosciences' management manipulating its earnings.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Xenetic Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Xenetic Biosciences Backtesting, Xenetic Biosciences Valuation, Xenetic Biosciences Correlation, Xenetic Biosciences Hype Analysis, Xenetic Biosciences Volatility, Xenetic Biosciences History and analyze Xenetic Biosciences Performance. To learn how to invest in Xenetic Stock, please use our How to Invest in Xenetic Biosciences guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Xenetic Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.